SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-042242
Filing Date
2023-12-20
Accepted
2023-12-20 16:30:14
Documents
3
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 6-K innatepharma6-k122023.htm 6-K 23613
2 EX-99.1 exhibit991-6xk.htm EX-99.1 17166
3 exhibit991aa.jpg GRAPHIC 217650
  Complete submission text file 0001628280-23-042242.txt   339349
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 231501662
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)